Vanguard Fiduciary Trust
BJDX icon

Vanguard Fiduciary Trust’s Bluejay Diagnostics BJDX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Buy
+10,225
New +$26.4K ﹤0.01% 4028

Other funds holding BJDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Vanguard Fiduciary Trust's BJDX Position: Q2 2026 in Review

Vanguard Fiduciary Trust opened a new position in Bluejay Diagnostics (BJDX) in Q2 2026: 10,225 shares worth $12.3K. The stake represents ﹤0.01% of the portfolio and ranks #4028 among its holdings.

8 funds tracked by Wall St. Rank hold BJDX as of Q2 2026.

  • Vanguard Fiduciary Trust held 10,225 shares of Bluejay Diagnostics worth $12.3K as of Q2 2026.
  • Bluejay Diagnostics was a new Vanguard Fiduciary Trust position in Q2 2026.
  • Bluejay Diagnostics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4028 holding.
  • 8 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.